RPS6KB1 and obesity disorder: Additionally, GLP-1/Exendin-4 reverses glucose’s effects on other metabolic sensors and energy regulators such as AMPK and p70S6K, and modulates its activity in metabolic alterations such as obesity or insulin resistance [21,30].